These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9323677)

  • 1. Renal duplex ultrasonography in the diagnosis and follow-up of a case of accelerated transplant rejection treated with OKT3.
    Salgado O; García R; Henríquez C; Rodríguez-Iturbe B
    J Ultrasound Med; 1997 Oct; 16(10):699-702. PubMed ID: 9323677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [OKT3 treatment of refractory renal allograft rejection].
    Xu J; Ma J; Bai X
    Zhonghua Wai Ke Za Zhi; 1997 Apr; 35(4):223-5. PubMed ID: 10374543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection.
    Woodle ES; Xu D; Zivin RA; Auger J; Charette J; O'Laughlin R; Peace D; Jollife LK; Haverty T; Bluestone JA; Thistlethwaite JR
    Transplantation; 1999 Sep; 68(5):608-16. PubMed ID: 10507477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of OKT3 as primary therapy for histologically confirmed acute renal allograft rejection in simultaneous kidney and pancreas transplant recipients.
    Peddi VR; Kamath S; Schroeder TJ; Munda R; First MR
    Transplant Proc; 1998 Mar; 30(2):285-7. PubMed ID: 9532041
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of OKT3 as primary therapy for histologically confirmed acute renal allograft rejection.
    Kamath S; Dean D; Peddi VR; Schroeder TJ; Alexander JW; Cavallo T; First MR
    Transplantation; 1997 Nov; 64(10):1428-32. PubMed ID: 9392306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of steroid resistant rejection following renal transplantation: benefits and risks of OKT3 therapy.
    Kehinde EO; Feehally J; Scriven SD; Veitch PS; Bell PR
    Transplant Proc; 1996 Jun; 28(3):1449-50. PubMed ID: 8658735
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients.
    Kumano K; Irie A; Mashimo S; Endo T; Koshiba K
    Transplant Proc; 1996 Jun; 28(3):1354-5. PubMed ID: 8658691
    [No Abstract]   [Full Text] [Related]  

  • 8. A blinded retrospective analysis of renal allograft pathology using the Banff schema: implications for clinical management.
    Dean DE; Kamath S; Peddi VR; Schroeder TJ; First MR; Cavallo T
    Transplantation; 1999 Sep; 68(5):642-5. PubMed ID: 10507482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OKT3 for primary therapy of the first rejection episode in kidney transplants.
    Tesi RJ; Elkhammas EA; Henry ML; Ferguson RM
    Transplantation; 1993 May; 55(5):1023-9. PubMed ID: 8497875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejection.
    Patschan D; Kribben A; Pietruck F; Lutz J; Binek M; Philipp T; Heemann U; Witzke O
    Nephron Clin Pract; 2006; 103(3):c94-9. PubMed ID: 16534238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of reversed diastolic flow in Doppler sonography of renal transplant.
    Mazuecos A; García T; Alonso F; García A; Tejuca F; Ceballos M; Calvo MJ; Rivero M
    Transplant Proc; 1997; 29(1-2):167-8. PubMed ID: 9122946
    [No Abstract]   [Full Text] [Related]  

  • 12. Predicting factors of long-term results of OKT3 therapy for steroid resistant acute rejection following cadaveric renal transplantation.
    Rostaing L; Chabannier MH; Modesto A; Rouzaud A; Cisterne JM; Tkaczuk J; Durand D
    Am J Nephrol; 1999; 19(6):634-40. PubMed ID: 10592356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of renal scintigraphy to management of patients with acute renal allograft dysfunction.
    Aktas A; Moray G; Karakayali H; Bilgin N
    Transplant Proc; 2002 Sep; 34(6):2099-101. PubMed ID: 12270329
    [No Abstract]   [Full Text] [Related]  

  • 14. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab.
    Alausa M; Almagro U; Siddiqi N; Zuiderweg R; Medipalli R; Hariharan S
    Clin Transplant; 2005 Feb; 19(1):137-40. PubMed ID: 15659147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of ICAM-1 and VCAM-1 in the skin after administration of the first dose of OKT3.
    ten Berge RJ; Buysmann S; van Diepen FN; Surachno S; Pals ST
    Transplant Proc; 1997; 29(1-2):325-7. PubMed ID: 9123022
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of renal allograft rejection with T10B9.1A31 or OKT3: final analysis of a phase II clinical trial.
    Waid TH; Lucas BA; Thompson JS; McKeown JW; Brown S; Kryscio R; Skeeters LJ
    Transplantation; 1997 Jul; 64(2):274-81. PubMed ID: 9256187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OKT3 rescue therapy for 63 refractory rejections in 405 renal allografts.
    Uchida K; Namii Y; Tominaga Y; Haba T; Tanaka H; Ichimori T; Uemura O; Morozumi K; Hayashi S; Yokoyama J; Takagi H
    Transplant Proc; 1996 Jun; 28(3):1358-9. PubMed ID: 8658693
    [No Abstract]   [Full Text] [Related]  

  • 18. ARFI-based tissue elasticity quantification and kidney graft dysfunction: first clinical experiences.
    Stock KF; Klein BS; Cong MT; Regenbogen C; Kemmner S; Büttner M; Wagenpfeil S; Matevossian E; Renders L; Heemann U; Küchle C
    Clin Hemorheol Microcirc; 2011; 49(1-4):527-35. PubMed ID: 22214724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose OKT3 treatment for rejection/induction in kidney and kidney-pancreas transplantation.
    Desai DM; Scandling JD; Knoppel C; Dafoe DC; Alfrey EJ
    Transplant Proc; 1998 Jun; 30(4):1552-4. PubMed ID: 9636630
    [No Abstract]   [Full Text] [Related]  

  • 20. [The potentials of ultrasonic duplex dopplerography in the early diagnosis of the dysfunction of a kidney allograft].
    Zakharov VV
    Klin Khir; 1996; (11-12):30-1. PubMed ID: 9182011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.